{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:36:41Z","timestamp":1792136201088,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04668-z","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:45:09Z","timestamp":1766828709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of machine learning models to identify potentially active compounds against tuberculosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Aman","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saatvik","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiranjit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushobhan","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"4668_CR1","unstructured":"Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA\u00a03.0\u00a0IGO."},{"key":"4668_CR2","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.2174\/1568026620666200903163921","volume":"20","author":"R Dey","year":"2020","unstructured":"Dey, R., Nandi, S., Samadder, A., Saxena, A. & Saxena, A. K. Exploring the potential inhibition of candidate drug molecules for clinical investigation based on their docking or crystallographic analyses against M. tuberculosis Enzyme Targets. Curr. Top. Med. Chem. 20, 2662\u20132680 (2020).","journal-title":"Curr. Top. Med. Chem."},{"key":"4668_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0040-1722535","volume":"57","author":"R Prasad","year":"2021","unstructured":"Prasad, R., Singh, A. & Gupta, N. Adverse drug reactions with first-line and second-line drugs in treatment of tuberculosis. Ann. Natl. Acad. Med. Sci. 57, 15\u201335 (2021).","journal-title":"Ann. Natl. Acad. Med. Sci."},{"key":"4668_CR4","doi-asserted-by":"publisher","first-page":"ftac046","DOI":"10.1093\/femspd\/ftac046","volume":"81","author":"K Moopanar","year":"2023","unstructured":"Moopanar, K., Nomfundo, A., Nyide, G., Senzani, S. & Mvubu, N. E. Clinical strains of Mycobacterium tuberculosis exhibit differential lipid metabolism-associated transcriptome changes in in vitro cholesterol and infection models. Pathogens Dis. 81, ftac046 (2023).","journal-title":"Pathogens Dis."},{"key":"4668_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","volume":"16","author":"I Smith","year":"2003","unstructured":"Smith, I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev. 16, 463\u2013496 (2003).","journal-title":"Clin. Microbiol. Rev."},{"key":"4668_CR6","unstructured":"https:\/\/www.cdc.gov\/tb\/signs-symptoms\/index.html last browsed on 10.05.2025."},{"key":"4668_CR7","unstructured":"https:\/\/www.webmd.com\/lung\/understanding-tuberculosis-basics; browsed on 31.12.2023."},{"key":"4668_CR8","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1086\/518655","volume":"196","author":"H McIlleron","year":"2007","unstructured":"McIlleron, H., Meintjes, G., Burman, W. J. & Maartens, G. Complications of antiretroviral therapy in patients with tuberculosis: Drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J. Infect. Dis. 196, S63\u2013S75 (2007).","journal-title":"J. Infect. Dis."},{"key":"4668_CR9","doi-asserted-by":"publisher","first-page":"AB154","DOI":"10.1016\/j.jaci.2009.12.604","volume":"125","author":"H Chantaphakul","year":"2010","unstructured":"Chantaphakul, H., Cheungpasitporn, W., Ruxrungtham, K. & Klaewsongkram, J. Adverse reaction to anti-tuberculosis drugs. J. Allergy Clin. Immunol. 125, AB154 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"4668_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ccm.2019.08.002","volume":"40","author":"SR Mase","year":"2019","unstructured":"Mase, S. R. & Chorba, T. Treatment of drug-resistant tuberculosis. Clin. Chest. Med. 40, 775\u2013795 (2019).","journal-title":"Clin. Chest. Med."},{"key":"4668_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/13543776.2022.2012151","volume":"32","author":"S Ahmed","year":"2021","unstructured":"Ahmed, S., Nandi, S. & Saxena, A. K. An updated patent review on drugs for the treatment of tuberculosis (2018-present). Expert Opin. Ther. Pat. 32, 243\u2013260 (2021).","journal-title":"Expert Opin. Ther. Pat."},{"key":"4668_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863","volume":"5","author":"KJ Seung","year":"2015","unstructured":"Seung, K. J., Keshavjee, S. & Rich, M. L. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb. Perspect. Med. 5, a017863 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"4668_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/13543776.2024.2419826","volume":"34","author":"S Benedetta","year":"2024","unstructured":"Benedetta, S. et al. Mycobacterium tuberculosis inhibitors: An updated patent review (2021\u2013present). Expert Opin. Ther. Pat. 34, 1215\u20131230 (2024).","journal-title":"Expert Opin. Ther. Pat."},{"key":"4668_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.14300","volume":"1467","author":"OJ Sekyere","year":"2020","unstructured":"Sekyere, O. J., Maningi, N. E. & Fourie, P. B. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: Current updates and emerging advances. Ann. New York Acad. Sci. 1467, 21\u201347 (2020).","journal-title":"Ann. New York Acad. Sci."},{"key":"4668_CR15","doi-asserted-by":"publisher","first-page":"1127916","DOI":"10.3389\/fcimb.2023.1127916","volume":"13","author":"C Wu","year":"2023","unstructured":"Wu, C. et al. Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis. Front. Cell. Infect. Microbiol 13, 1127916. https:\/\/doi.org\/10.3389\/fcimb.2023.1127916 (2023).","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"4668_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2020.03.007","volume":"220","author":"GS Shetye","year":"2020","unstructured":"Shetye, G. S., Franzblau, S. G. & Cho, S. New tuberculosis drug targets, their inhibitors, and potential therapeutic impact. Transl. Res. 220, 68\u201397 (2020).","journal-title":"Transl. Res."},{"key":"4668_CR17","first-page":"123","volume":"36","author":"DV Opromolla","year":"1965","unstructured":"Opromolla, D. V., de Lima, L. S. & Caprara, G. Rifamycin SV in the treatment of lepromatous leprosy. Lepr. Rev. 36, 123\u2013131 (1965).","journal-title":"Lepr. Rev."},{"key":"4668_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbab068","volume":"22","author":"Q Ye","year":"2021","unstructured":"Ye, Q. et al. Identification of active molecules against Mycobacterium tuberculosis through machine learning. Brief. Bioinform. 22, 1\u201315 (2021).","journal-title":"Brief. Bioinform."},{"key":"4668_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijtb.2020.09.003","volume":"68","author":"U Deb","year":"2021","unstructured":"Deb, U. & Biswas, S. Pretomanid: The latest USFDA-approved anti-tuberculosis drug. Indian J. Tuberc. 68, 287\u2013291 (2021).","journal-title":"Indian J. Tuberc."},{"key":"4668_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie, F. et al. Treatment of highly drug-resistant pulmonary tuberculosis. N. Engl. J. Med. 382, 893\u2013902 (2020).","journal-title":"N. Engl. J. Med."},{"key":"4668_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","volume":"384","author":"SE Dorman","year":"2021","unstructured":"Dorman, S. E. et al. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis. N. Engl. J. Med. 384, 1705\u20131718 (2021).","journal-title":"N. Engl. J. Med."},{"key":"4668_CR22","volume":"50","author":"DR Silva","year":"2025","unstructured":"Silva, D. R. et al. Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: A systematic review. J. Bras. Pneumol. 50, e20240295 (2025).","journal-title":"J. Bras. Pneumol."},{"key":"4668_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois, V. A. & Rubin, E. J. Anti-tuberculosis treatment strategies and drug development: Challenges and priorities. Nat. Rev. Microbiol. 20, 685\u2013701 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"4668_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.755459","volume":"11","author":"V Singh","year":"2021","unstructured":"Singh, V. Tuberculosis drug discovery & development: Drug targets, chemical matter, and approaches. Front. Cell. Infect. Microbiol. 11, 755459 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"4668_CR25","doi-asserted-by":"publisher","first-page":"13259","DOI":"10.3390\/ijms222413259","volume":"22","author":"MA Ejalonibu","year":"2021","unstructured":"Ejalonibu, M. A. et al. Drug discovery for Mycobacterium tuberculosis using structure-based computer-aided drug design approach. Int. J. Mol. Sci. 22, 13259 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"4668_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.tube.2009.05.008","volume":"89","author":"S Ananthan","year":"2009","unstructured":"Ananthan, S. et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis 89, 334\u2013353 (2009).","journal-title":"Tuberculosis"},{"key":"4668_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tube.2011.05.005","volume":"92","author":"RC Reynolds","year":"2012","unstructured":"Reynolds, R. C. et al. High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv. Tuberculosis 92, 72\u201383 (2012).","journal-title":"Tuberculosis"},{"key":"4668_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tube.2009.07.006","volume":"89","author":"JA Maddry","year":"2009","unstructured":"Maddry, J. A. et al. Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis 89, 354\u2013363 (2009).","journal-title":"Tuberculosis"},{"key":"4668_CR29","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.drudis.2016.06.013","volume":"21","author":"AU Khan","year":"2016","unstructured":"Khan, A. U. Descriptors and their selection methods in QSAR analysis: Paradigm for drug design. Drug. Discov. Today 21, 1291\u20131302 (2016).","journal-title":"Drug. Discov. Today"},{"key":"4668_CR30","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","volume":"119","author":"X Yang","year":"2019","unstructured":"Yang, X., Wang, Y., Byrne, R., Schneider, G. & Yang, S. Concepts of artificial intelligence for computer-assisted drug discovery. Chem. Rev. 119, 10520\u201310594 (2019).","journal-title":"Chem. Rev."},{"key":"4668_CR31","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/biom11121750","volume":"11","author":"ME Mswahili","year":"2021","unstructured":"Mswahili, M. E., Martin, G. L., Woo, J., Choi, G. J. & Jeong, Y.-S. Antimalarial drug predictions using molecular descriptors and machine learning against plasmodium falciparum. Biomolecules 11, 1750 (2021).","journal-title":"Biomolecules"},{"key":"4668_CR32","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.21037\/jtd.2018.01.91","volume":"10","author":"Y Xiong","year":"2018","unstructured":"Xiong, Y. et al. Automatic detection of Mycobacterium tuberculosis using artificial intelligence. J. Thorac. Dis. 10, 1936\u20131940 (2018).","journal-title":"J. Thorac. Dis."},{"key":"4668_CR33","doi-asserted-by":"publisher","first-page":"935080","DOI":"10.3389\/fmed.2022.935080","volume":"9","author":"S Liang","year":"2022","unstructured":"Liang, S. et al. The application of artificial intelligence in the diagnosis and drug resistance prediction of pulmonary tuberculosis. Front. Med. (Lausanne) 9, 935080 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"4668_CR34","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1038\/s41598-020-62368-2","volume":"10","author":"S Jamal","year":"2020","unstructured":"Jamal, S. et al. Artificial intelligence and machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis. Sci. Rep. 10, 5487 (2020).","journal-title":"Sci. Rep."},{"key":"4668_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102143","volume":"131","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. An accurate artificial intelligence system for the detection of pulmonary and extra pulmonary Tuberculosis. Tuberculosis 131, 102143 (2021).","journal-title":"Tuberculosis"},{"key":"4668_CR36","doi-asserted-by":"publisher","first-page":"2399428","DOI":"10.1155\/2022\/2399428","volume":"2022","author":"V Acharya","year":"2022","unstructured":"Acharya, V. et al. AI-assisted tuberculosis detection and classification from chest x-rays using a deep learning normalization-free network model. Comput. Intell. Neurosci. 2022, 2399428 (2022).","journal-title":"Comput. Intell. Neurosci."},{"key":"4668_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/wcms.1187","volume":"4","author":"RA Lewis","year":"2014","unstructured":"Lewis, R. A. & Wood, D. Modern 2D QSAR for drug discovery. Wiley Interdiscip. Rev. Comput. Mol. Sci. 4, 505\u2013522 (2014).","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"4668_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tube.2017.01.005","volume":"103","author":"S Ekins","year":"2017","unstructured":"Ekins, S. et al. Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I. Tuberculosis (Edinb). 103, 52\u201360 (2017).","journal-title":"Tuberculosis (Edinb)."},{"key":"4668_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/17460441.2022.2108785","volume":"17","author":"DA Winkler","year":"2022","unstructured":"Winkler, D. A. The impact of machine learning on future tuberculosis drug discovery. Expert Opin. Drug Discov. 17, 925\u2013927 (2022).","journal-title":"Expert Opin. Drug Discov."},{"key":"4668_CR40","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1021\/ci800143n","volume":"48","author":"P Prathipati","year":"2008","unstructured":"Prathipati, P., Ma, N. L. & Keller, T. H. Global Bayesian models for the prioritization of antitubercular agents. J. Chem. Inf. Model. 48, 2362\u20132370 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"4668_CR41","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1021\/ci500077v","volume":"54","author":"S Ekins","year":"2014","unstructured":"Ekins, S., Pottorf, R. & Reynolds, R. C. Looking back to the future: predicting in vivo efficacy of small molecules versus mycobacterium tuberculosis. J. Chem. Inf. Model. 54, 1070\u20131082 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"4668_CR42","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1021\/acs.molpharmaceut.8b00083","volume":"15","author":"T Lane","year":"2018","unstructured":"Lane, T., Russo, D. P. & Zorn, K. M. Comparing and validating machine learning models for mycobacterium tuberculosis drug discovery. Mol. Pharm. 15, 4346\u20134360 (2018).","journal-title":"Mol. Pharm."},{"key":"4668_CR43","unstructured":"https:\/\/www.ebi.ac.uk\/chembl\/search_results\/tuberculosis browsed on 09.07.2024."},{"key":"4668_CR44","unstructured":"RDKit Documentation. RDKit: Open-Source Cheminformatics Software. Available from:\u00a0https:\/\/www.rdkit.org\/docs\/."},{"key":"4668_CR45","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman, L., Friedman, J., Olshen, R. & Stone, C. Classification and regression trees (Wadsworth Int. Group, 1984)."},{"key":"4668_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1109\/TIT.1967.1053964","volume":"13","author":"TM Cover","year":"1967","unstructured":"Cover, T. M. & Hart, P. E. Nearest neighbor pattern classification. IEEE Trans. Inf. Theory 13, 21\u201327 (1967).","journal-title":"IEEE Trans. Inf. Theory"},{"key":"4668_CR47","volume-title":"Pattern classification","author":"RO Duda","year":"2001","unstructured":"Duda, R. O., Hart, P. E. & Stork, D. G. Pattern classification 2nd edn. (Wiley, 2001).","edition":"2"},{"key":"4668_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning: Data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie, T., Tibshirani, R. & Friedman, J. The elements of statistical learning: Data mining, inference, and prediction 2nd edn. (Springer, 2009).","edition":"2"},{"key":"4668_CR49","volume-title":"Deep learning","author":"I Goodfellow","year":"2016","unstructured":"Goodfellow, I., Bengio, Y. & Courville, A. Deep learning (MIT Press, 2016)."},{"key":"4668_CR50","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun, Y., Bengio, Y. & Hinton, G. Deep learning. Nature 521, 436\u2013444 (2015).","journal-title":"Nature"},{"key":"4668_CR51","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. XGBoost: A scalable tree boosting system. In\u00a0Proceedings of the 22nd ACM SIGKDD International conference on knowledge discovery and data mining, 2016, 785\u2013794 (2016).","DOI":"10.1145\/2939672.2939785"},{"key":"4668_CR52","doi-asserted-by":"publisher","DOI":"10.1201\/b12207","volume-title":"Ensemble methods: Foundations and algorithms","author":"Z-H Zhou","year":"2012","unstructured":"Zhou, Z.-H. Ensemble methods: Foundations and algorithms (CRC Press, 2012)."},{"key":"4668_CR53","first-page":"37","volume":"2","author":"A Powers","year":"2011","unstructured":"Powers, A. Evaluation: From precision, recall, and F-measure to ROC, informedness, markedness & correlation. J. Mach. Learn. Technol. 2, 37\u201363 (2011).","journal-title":"J. Mach. Learn. Technol."},{"key":"4668_CR54","first-page":"30","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg, S. M. & Lee, S. I. A unified approach to interpreting model predictions. Adv. Neural Inform. Process Syst. 30, 30 (2017).","journal-title":"Adv. Neural Inform. Process Syst."},{"key":"4668_CR55","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","volume":"2","author":"SM Lundberg","year":"2018","unstructured":"Lundberg, S. M., Nair, B. & Vavilala, M. S. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat. Biomed. Eng. 2, 749\u2013760 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"4668_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04668-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:02:34Z","timestamp":1777136554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04668-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4668"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04668-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"45678"}}